APA (7th ed.) Citation

Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, . . . Guillermina Ferro-Flores. (2023). Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using ¹⁷⁷Lu-iPSMA and ¹⁷⁷Lu-DOTATOC: Experience after 905 Treatment Doses. MDPI AG.

Chicago Style (17th ed.) Citation

Myrna Luna-Gutiérrez, et al. Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using ¹⁷⁷Lu-iPSMA and ¹⁷⁷Lu-DOTATOC: Experience After 905 Treatment Doses. MDPI AG, 2023.

MLA (9th ed.) Citation

Myrna Luna-Gutiérrez, et al. Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using ¹⁷⁷Lu-iPSMA and ¹⁷⁷Lu-DOTATOC: Experience After 905 Treatment Doses. MDPI AG, 2023.